Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of LY2216684 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects.

Next Previous
Search
Trial Profile

Effect of LY2216684 on Oral Contraceptive Pharmacokinetics in Healthy Female Subjects.

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 29 Oct 2018

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Edivoxetine (Primary) ; Ethinylestradiol/norgestimate
  • Indications Depressive disorders; Pregnancy
  • Focus Pharmacokinetics

Most Recent Events

  • 24 Jan 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 02 Sep 2011 Planned End Date changed from 1 Oct 2011 to 1 Dec 2011 as reported by ClinicalTrials.gov.
  • 18 Aug 2011 Planned end date changed from Nov 2011 to Oct 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top